Variant report
Variant | nsv512310 |
---|---|
Chromosome Location | chr13:38047833-38049592 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-EXOSC8-5 | chr13:38048777-38048839 | NONHSAT033247 |
2 | lnc-EXOSC8-5 | chr13:38048795-38048839 | l_812_chr13:38039862-38051088_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574589803 | chr13:38047864-38047865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369234870 | chr13:38047884-38047885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141647797 | chr13:38047892-38047893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571330082 | chr13:38047893-38047894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73464453 | chr13:38047950-38047951 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs552473070 | chr13:38047954-38047955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562526381 | chr13:38048019-38048020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150081333 | chr13:38048061-38048062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs17055791 | chr13:38048126-38048127 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs568167175 | chr13:38048180-38048181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372961436 | chr13:38048223-38048224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556946397 | chr13:38048238-38048239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538757171 | chr13:38048242-38048243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547637796 | chr13:38048278-38048279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17055796 | chr13:38048308-38048309 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs539731608 | chr13:38048317-38048318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138624677 | chr13:38048350-38048351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575311143 | chr13:38048360-38048361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369253235 | chr13:38048418-38048419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559489420 | chr13:38048431-38048432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190152068 | chr13:38048439-38048440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376957275 | chr13:38048463-38048464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541654991 | chr13:38048490-38048491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577002073 | chr13:38048491-38048492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6563549 | chr13:38048496-38048497 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs554136858 | chr13:38048501-38048502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562488654 | chr13:38048529-38048530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539531221 | chr13:38048577-38048578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113027194 | chr13:38048578-38048579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141624207 | chr13:38048640-38048641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181414601 | chr13:38048643-38048644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377416824 | chr13:38048687-38048688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530442959 | chr13:38048742-38048743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548136183 | chr13:38048760-38048761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs371076939 | chr13:38048817-38048818 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs550182111 | chr13:38048870-38048871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186615911 | chr13:38048885-38048886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs118000942 | chr13:38048917-38048918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs8002916 | chr13:38048918-38048919 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs540074258 | chr13:38048934-38048935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74809500 | chr13:38048940-38048941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544483491 | chr13:38048941-38048942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570323199 | chr13:38048963-38048964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532361642 | chr13:38048997-38048998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536172413 | chr13:38049006-38049007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554577613 | chr13:38049011-38049012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146125646 | chr13:38049054-38049055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533635301 | chr13:38049121-38049122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78196278 | chr13:38049124-38049125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553872299 | chr13:38049131-38049132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:38046000-38049200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:38048400-38049000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr13:38048600-38049800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr13:38048800-38049800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr13:38048800-38051200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr13:38049000-38049400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr13:38049000-38049800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr13:38049000-38049800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr13:38049000-38049800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr13:38049200-38049400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr13:38049200-38049600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr13:38049200-38049600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr13:38049200-38051200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr13:38049400-38049600 | Enhancers | Colon Smooth Muscle | Colon |
15 | chr13:38049400-38049800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr13:38049400-38051000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
17 | chr13:38049400-38051400 | Enhancers | Muscle Satellite Cultured Cells | -- |
18 | chr13:38049400-38051400 | Enhancers | NH-A | brain |
19 | chr13:38049400-38051600 | Enhancers | Osteobl | bone |
20 | chr13:38049400-38051800 | Enhancers | NHDF-Ad | bronchial |